Where to Request an Ocular Microbiota Evaluation

What is the Ocular Microbiota Test

The ocular microbiota test is an advanced diagnostic analysis aiming to identify microorganisms on the ocular surface, generally through 16S rRNA genomic sequencing or other next‑generation molecular techniques.

This method aims to detect potential bacterial flora alterations (dysbiosis) that may be associated with chronic ocular pathologies, supporting targeted strategies based on ocular microbiota physiology.

In specific clinical contexts, the test can also be performed using PCR methodology for the targeted detection of specific pathogens, useful in suspected infections or to monitor targeted therapies. Even in these situations, it remains a second‑level diagnostic tool, to be proposed cautiously and only when truly indicated.

When it May Be Indicated

Ocular microbiota analysis may be useful to support diagnostic framing in patients with chronic or refractory pathologies. It does not replace the ophthalmological examination or first‑line tests. For more details on clinical correlations, consult the page dedicated to ocular dysbiosis.

• Severe dry eye syndrome refractory to standard therapies
• Chronic or recurrent blepharitis and conjunctivitis
• Chronic ocular surface inflammation of unclear origin
• Persistent Meibomitis (Meibomian gland dysfunction)
• Specific evaluations during complex pre‑surgical preparation
• Contact lens wearers with repeated inflammatory episodes

How the Investigation Works

To learn general details about the analysis methodology and medical interpretation, visit the dedicated page on how the test works. Sampling is always performed in a medical setting and is not proposed as a general screening.

• Evaluation and Sampling: After clinical assessment, a non‑invasive conjunctival swab is performed in the outpatient clinic, only if deemed appropriate.
• Laboratory Analysis: Sample processing via 16S rRNA genomic sequencing or PCR at independent, specialised laboratories; the doctors have no financial interest in these services.
• Clinical Framing: Specialist interpretation of the report to develop a possible personalised support protocol, always integrated with standard ophthalmological therapy.

Conditions Often Associated with Dysbiosis

Research highlights how ocular microbiota alterations can be a co‑factor in several inflammatory conditions. The test, when indicated, does not replace conventional investigations on these diseases. For more ophthalmological information, visit medicioculisti.it:

• Dry Eye Syndrome
• Chronic Anterior/Posterior Blepharitis
• Meibomitis (MGD)
• Recurrent Inflammatory Conjunctivitis
• Anomalous keratitis and corneal infections

Reference Clinical Centers

Clinical Hub - Ravenna

The specialist evaluations required for potential prescription and sampling are carried out in our clinical facilities, within structured Systemic Ophthalmology pathways. Any indication for the test is discussed transparently with the patient, clarifying benefits, limitations and external laboratory costs.

Systemic Clinical Approach

The potential analysis of the ocular microbiota is part of a broader systemic ophthalmological approach. The goal is to frame visual symptoms by evaluating possible interconnections with metabolic status, gut microbiota and general inflammation, without replacing evidence‑based protocols.

To learn more about this integrated method, visit the homepage or consult the resources dedicated to physiology, dysbiosis and therapeutic support.